Blue Spoon outlines a new strategy for pharmaceutical industries

Aug 25 2009

Blue Spoon Consulting Group, LLC, today published a white paper that frames a new innovation space for strategy in the pharmaceutical industry. As momentum grows for performance-based contracting, connected health, and collaborative business models, drug companies will need to rethink their value proposition in a broader context. Available for download through the Blue Spoon Consulting website (www.bluespoonconsulting.com), the white paper explores the business implications of these structural changes, and helps develop options for significant revenue growth and organizational focus.

Blue Spoon is a leading strategy and marketing innovation consultancy serving the global pharmaceutical, health products, and information technology industries. Blue Spoon was the first to publish a new commercial model for drug marketing¹, the first to design a new architecture for grand strategy in the pharmaceutical industry, and has pioneered a framework to improve business performance at a system level, an approach that enables an evolutionary leap in solutions for growth and competitive advantage. Visit: www.bluespoonconsulting.com.

¹Singer J. Systems marketing: A new operating model for pharmaceutical marketing. Jrnl Consumer Behaviour. 2005;4:(6):480-495.